title: Minimizing waste during preparation of blinatumomab infusions.
authors.affiliation: Department of Pharmacy.
authors.forename: Bernard L
authors.initials: BL
authors.lastname: Marini
authors.affiliation: Department of Pharmacy.
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Wechter
authors.affiliation: Division of Hematology and OncologyDepartment of Internal Medicine.
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Burke
authors.affiliation: Division of Hematology and OncologyDepartment of Internal Medicine.
authors.forename: Dale
authors.initials: D
authors.lastname: Bixby
authors.affiliation: Department of Pharmacyajperis@med.umich.eduUniversity of Michigan Health SystemAnn Arbor, MI.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Perissinotti
mesh_terms: D018033:Antibodies, Bispecific / Q000008:administration & dosage / Q000191:economics*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000191:economics*; D004339:Drug Compounding / Q000191:economics / Q000379:methods; D005252:Fees, Pharmaceutical; D006801:Humans; D007262:Infusions, Intravenous; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000191:economics
chemical_list: D018033:Antibodies, Bispecific; D000970:Antineoplastic Agents; C510808:blinatumomab